NuriFlex Holdings Inc. and Talken GmbH Sign MoU for Metaverse and NFT Wallet and Platform Project
6.1.2022 20:00:00 EET | Business Wire | Press release
NuriFlex Holdings Inc. (“NuriFlex Holdings”) announced that it has signed a memorandum of understanding (“MoU”) with Talken GmbH (“Talken”). The two companies intend to collaborate in the metaverse token project and the multichain decentralized NFT wallet and its platform (“Project”) in various regions based on robust technology and business development capabilities of the parties.
One of NuriFlex Holdings’ businesses involves the design and development of a blockchain-based metaverse ecosystem to offer various virtual worlds and related digital experiences for various services. NuriFlex Holdings is currently investing in the metaverse project that is expected to launch this year, offering global users participation in its virtual metaverse world where they can create and interact with other users like in real life.
Talken GmbH provides a service called ‘Talken’, which is a multi-chain decentralized NFT wallet supported by one of the largest Korean communities. It is a seamlessly interoperable multi-chain NFT Suite, where K-pop stars, artists, and influencers can mint, auction, store, and trade NFTs. Talken NFT Suite offers various products for every NFT lifecycle stage such as NFT wallet, NFT marketplace, simple NFT minting tool and more.
“We are excited to partner and collaborate with Talken GmbH on our metaverse and NFT platform projects. The blockchain technology experience and business development capabilities that NuriFlex Holdings and Talken GmbH bring together will be a great advantage to successfully accomplish new business opportunities and the initial step to our future token projects,” said Songman Cho, Chairman of NuriFlex Holdings Inc.
“We hope this will be the first of many partnerships to come between Nuri Group and Talken. I trust there will be many synergies to be made between Nuri’s solution for blockchain-based digital services and Talken’s unique multichain NFT platform,” said Minsu Ju, Chief Executive Officer of Talken GmbH.
About NuriFlex Holdings Inc.
Located in Vancouver, BC, Canada, NuriFlex Holdings Inc. is a parent company to the Nuri Group of companies, including NuriFlex Inc. in the USA and NuriFlex Co., Ltd. in South Korea. The NuriFlex Group of companies utilize telecommunication technologies and applications to supply a simple, convergent solution for the utilities industry, payment solution and blockchain-based digital service platform. We provide a complete energy IoT solution which enhances the utility of connected micro and smart grids throughout our clients’ systems. The blockchain embedded solution and service will be NuriFlex Group’s next-generation business. Our existing solutions will be integrated with our blockchain technology to make us one of the top integrated solution providers in the international market. Learn more at www.nuri.ca
About Talken GmbH
Talken is the multi-chain decentralized NFT wallet with the largest community. It is a seamlessly interoperable multi-chain NFT Suite, where K-pop stars, artists, and influencers can mint, auction, store, and trade NFTs. Talken is an open NFT ecosystem bridging untapped NFT enthusiasts in Korea to Talken’s native NFTs and other famous NFTs by protocols such as NBA TopShot, Rarible, OpenSea, and more. Our mission is to push for an inclusive and border-less NFT expansion and empower digital creators and collectors with better tools and services to bring NFT mainstream. Learn more at www.talken.io
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220107005002/en/
Contact information
NuriFlex Holdings Inc.
Elizabeth Park, CEO
ir@nuri.ca
www.nuri.ca
Talken GmbH
Minsu Ju, CEO
biz@talken.io
www.talken.io
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Safe Software to Increase Global Headcount by Over 15% as Demand for AI-Ready Data Grows2.9.2026 16:00:00 EEST | Press release
Safe Software, the creator of FME, the only All-Data, Any-AI enterprise integration platform with true support for spatial data, today announced it is recruiting for more than 60 roles throughout the remainder of 2026. The hiring will take the company past 400 employees, increasing headcount by over 15%, with new positions across the United Kingdom, the United States and Canada. The expansion follows a year in which Safe crossed $100 million in annual revenue, growing close to 20 percent year over year and moving ahead of schedule on its target of $250 million by 2028. The company also grew its employee base by over 20% in the same period. "The incredible growth that we’ve seen over the last 30+ years at Safe has always been a testament to the great people behind what we do," said Don Murray, Co-Founder and CEO of Safe Software. "Almost every organization we speak to is trying to get its data ready for AI, and most of them are realizing that the hard part is not the model, it is the da
Egon Zehnder Names Ayşe Güçlü Onur Global Human Resources Practice Leader2.9.2026 16:00:00 EEST | Press release
Egon Zehnder has appointed Ayşe Güçlü Onur as Global Leader of its Human Resources Practice. This appointment comes as companies and boards increasingly look to CHROs to help shape business strategy, lead transformation, build leadership pipelines, and navigate major shifts in culture and the workforce. "CHROs used to be evaluated by how well they supported the business. Today, the best drive it," said Onur. "Our role is to help CHROs move from a seat at the table to a hand in business growth. We help them connect leadership decisions, talent, and culture directly to elevated performance. That's the shift Egon Zehnder is built to guide with our leadership advisory services." Egon Zehnder’s Human Resources Practice partners with companies to discover, develop, and transform future-ready CHROs, helping them shape the future of the function. This includes executive search, leadership assessment and development, board effectiveness, culture, succession planning, organizational transformati
Owkin to License K Pro AI Scientist and Multimodal Oncology and Immunology Data to Boehringer Ingelheim2.9.2026 15:00:00 EEST | Press release
Owkin, the agentic AI company striving to transform drug discovery and development for biopharma, today announced a license agreement with Boehringer Ingelheim for K Pro, Owkin’s AI Scientist, together with multimodal patient data, aiming to speed up the discovery process across multiple indications in oncology and immunology. This agreement builds upon an initial pilot undertaken by Owkin with Boehringer in 2025. In that pilot Owkin delivered deep spatial insights into the tumor microenvironment of a gene target through its MOSAIC dataset. Under the new agreement, Owkin will license multimodal oncology data to Boehringer and will generate new multimodal data in immunology. Owkin licenses, sources and generates multimodal patient data in collaboration with its global patient data network. Boehringer Ingelheim’s teams will access and analyze this data through K Pro, which provides a single environment to interrogate data and run reproducible analyses. K Pro’s reasoning capabilities supp
Biocytogen Enters into Non-Exclusive Licensing Agreement with Qilu Pharmaceutical for a Fully Human VHH Antibody to Support Innovative Drug Development in Neuroscience2.9.2026 15:00:00 EEST | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, SSE: 688796; HKEX: 02315) today announced that it has entered into a non-exclusive licensing agreement with Qilu Pharmaceutical Co., Ltd. (“Qilu Pharmaceutical”) for a fully human VHH antibody molecule. Under the agreement, Biocytogen will grant Qilu Pharmaceutical non-exclusive rights to a fully human VHH antibody molecule to support its research and development of innovative therapeutics in the neuroscience field. The licensed VHH antibody molecule was generated from Biocytogen’s proprietary RenNano® platform. The RenNano® platform is designed to discover fully human VHH antibody molecules with favorable specificity, binding affinity, and developability, and can generate molecular building blocks for the design and development of VHH antibodies, bispecific/multispecific antibodies, antibody-drug conjugates, and other innovative modalities. Through this license, Qilu Pharmaceutical may advance the research and development o
Croma-Pharma Introduces Electronic Instructions for Use Across the saypha ® Portfolio2.9.2026 14:37:00 EEST | Press release
Croma-Pharma has introduced electronic Instructions for Use (eIFU) across its saypha® portfolio in markets where applicable regulations permit electronic Instructions for Use to replace printed versions. The transition expands digital access to essential product information for healthcare professionals while reducing the use of printed documentation. Healthcare professionals can access the current approved Instructions for Use by scanning the QR code on the saypha® folding box. The eIFU platform provides direct digital access to the latest approved Instructions for Use. "Innovation extends beyond product development. It also includes how we provide healthcare professionals with access to essential product information," said Andreas Prinz, Chief Executive Officer of Croma-Pharma. "The introduction of electronic Instructions for Use across the saypha® portfolio reflects our focus on practical digital solutions that support healthcare professionals and align with evolving regulatory requi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom